Many investors appear to be quite bearish on Myriad Genetics, Inc. (MYGN), especially if you look at the percentage of the float that is sold short for this stock. Currently, 52.1% of the float is sold short, suggesting an extreme level of bearishness for MYGN.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we have a Zacks Rank #1 (Strong Buy) on MYGN, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of MYGN to move higher in the weeks ahead.

 
MYRIAD GENETICS (MYGN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Myriad Genetics Charts.
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Myriad Genetics Charts.